Add BrightSurf on Google Email

University College London


New approach to mental health care reduces hospital admissions

A new approach to mental health care, Open Dialogue, has been shown to reduce hospital admissions and improve satisfaction with care. The study found that those treated with Open Dialogue had a higher odds of never being admitted to psychiatric inpatient hospital care and lower odds of re-referral to crisis care.

SourceUniversity College London·JournalThe Lancet Psychiatry·TypeRandomized controlled/clinical trial·DateAug 26, 2026

Has autism become too broad to be useful?

The autism spectrum has become increasingly broad, leading to concerns about misdiagnosis and the loss of its meaning. Dame Uta Frith argues that a rethink is needed to examine whether the autism spectrum has become too broad, risking misunderstanding people's needs and misdirecting care.

SourceUniversity College London·JournalPsychological Medicine·TypeCommentary/editorial·DateAug 3, 2026

Living by the coast linked to worse midlife health

A new study published in BMJ Public Health found that people who live by the coast in midlife are more likely to have two or more diagnosed chronic conditions. The researchers attribute this to higher deprivation and selective migration patterns, where individuals with worse health tend to remain in or move to coastal areas.

SourceUniversity College London·JournalBMJ Public Health·TypeObservational study·DateJul 30, 2026

Early surgery for bacterial eye infection offers hope to patients

A study published in Communications Medicine found that early vitrectomy surgery can be more beneficial for patients' vision than the current antibiotic-first approach. After six months, patients who received this treatment showed a median improvement of 40 additional letters they could read compared to those receiving antibiotics.

SourceUniversity College London·JournalCommunications Medicine·TypeRandomized controlled/clinical trial·DateJul 30, 2026

AI reveals cancer therapy’s effectiveness

A new study published in eBioMedicine shows that combining irinotecan with standard chemoradiotherapy improves survival against advanced rectal cancer, particularly in those with high concentrations of cancerous cells. The AI-powered analysis revealed a 43% reduction in cancer recurrence and a 50% reduction in death risk.

SourceUniversity College London·JournalEBioMedicine·TypeObservational study·DateJul 27, 2026

Weight loss drugs could help with binge eating disorder

A systematic review and meta-analysis found that weight loss drugs can reduce key symptoms of binge eating disorder, including binge eating episodes, loss-of-control eating, and emotional eating. The study suggests that these medications could be an important part of treatment plans for people with binge eating disorder.

SourceUniversity College London·JournalEClinicalMedicine·TypeMeta-analysis·DateJul 15, 2026

Long Covid rehab program helps with return to work and focus

A new clinical trial led by University College London researchers found that ten weeks of cognitive rehabilitation can help people with long Covid symptoms such as brain fog achieve their goals in returning to work and hobbies. The treatment yielded benefits that lasted for at least six months for most participants.

SourceUniversity College London·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJul 1, 2026

Childbirth is not uniquely difficult to humans

Researchers at UCL found that some small-bodied primates experience a tight cephalopelvic fit during childbirth due to their large newborn heads. These species, such as American monkeys and bushbabies, have developed adaptations to make the process less difficult, including pelvic expansion or delayed pelvic bone fusion.

SourceUniversity College London·JournalNature Ecology & Evolution·TypeData/statistical analysis·DateJun 29, 2026

New trial aims to extend immune system lifespan

A new trial aims to restore the function of worn-out T cells, a type of white blood cell that helps coordinate the body's immune response. The Phase 1 trial will focus on exhausted or senescent T cells, which accumulate with age and in chronic disease, and may help improve immune resilience and support healthier ageing.

SourceUniversity College London·TypeRandomized controlled/clinical trial·DateJun 17, 2026

Weight loss drugs risk widening health inequalities

The use of weight loss medications like semaglutide and tirzepatide could deepen existing health inequalities if patients lack access to nutrition advice, healthy food, and ongoing healthcare support. Researchers warn that poorer patients may face barriers to using these treatments safely and maintaining health improvements over time.

SourceUniversity College London·JournalNature Medicine·TypeCommentary/editorial·DateJun 1, 2026

Neuropixels Opto sheds new light on deepest regions of the brain

Researchers have developed a new device called Neuropixels Opto that can record and manipulate neuron activity in the brain. The device, published in Nature Methods, integrates electrophysiology and optogenetics to provide unprecedented insight into neural circuits and neurological conditions such as Alzheimer's disease and schizophrenia.

SourceUniversity College London·JournalNature Methods·TypeExperimental study·DateJun 1, 2026

Weight loss drug semaglutide helps patients who do not respond to bariatric surgery

A new study published in Nature Medicine finds that semaglutide improves weight loss and metabolic health outcomes in patients who do not respond well to bariatric surgery. Patients taking semaglutide showed significant weight loss from body fat, improved blood sugar levels, and better quality of life.

SourceUniversity College London·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateMay 22, 2026

Harm from missing incidents among people with dementia

A new analysis of police data reveals that one in 10 missing incidents among people with dementia results in serious harm. The study highlights the need for preventative action to keep people with dementia safe and finds that older age, night disappearances, and longer durations of absence are risk factors for harm.

SourceUniversity College London·JournalAge and Ageing·TypeMeta-analysis·DateMay 12, 2026

Risk of drug poisoning if gabapentinoid painkillers taken with other medications

A new study by University College London found that gabapentinoids, prescribed for chronic pain, double the risk of hospitalization for drug poisoning when combined with benzodiazepines or opioids. The risk persists even after starting gabapentinoid treatment, suggesting they may not be an effective solution to reduce poisoning risks.

SourceUniversity College London·JournalPLOS Medicine·TypeObservational study·DateApr 16, 2026